Prospective Tissue Collection Research Protocol

  • End date
    Aug 31, 2025
  • participants needed
  • sponsor
    Achilles Therapeutics UK Limited
Updated on 26 May 2022
breast cancer
lung cancer
neutrophil count
blood transfusion


This is a multi-solid tumour research study which collects tumour samples from patients alongside a matched whole blood, and/or leukapheresis product for the development of manufacturing processes for potential immunotherapies.


During standard of care surgery tumour samples which are surplus to the requirements of the patients diagnostic/treatment pathway will be procured along with a matched whole blood and/or leukapheresis sample. In some instances patients may consent to provide a non-standard of care, non-invasive research biopsy.

Within 28-42 days following procurement of samples patients will be required to participate in a safety follow up call for assessment of any procedure related adverse events.

Condition Solid Tumor
Treatment Tumour tissue collection
Clinical Study IdentifierNCT03517917
SponsorAchilles Therapeutics UK Limited
Last Modified on26 May 2022


Yes No Not Sure

Inclusion Criteria

Aged ≥ 18 years
Written informed patient consent for tissue, blood collection or leukapheresis, including storage and manipulation
Suspected or confirmed diagnosis of selective solid tumours with either primary, recurrent or metastatic disease
Patient is scheduled for surgical excision and/or collection of multiple tissue samples via image or device guided biopsy, has a superficial skin or subcutaneous lymph node metastasis that can be safely accessed for the purposes of the study
Haemoglobin(Hb) ≥ 10g/dL without transfusion support for at least 3 weeks
White cell count ≥ 3 x 10^9/L
Negative laboratory test for blood borne pathogens (see exclusion criterion)
For selected solid tumours and leukapheresis procedure additional inclusion criteria apply

Exclusion Criteria

Inadequate peripheral venous access precluding collection of blood
Pregnant or breastfeeding women
Known/laboratory confirmed diagnosis of an active infectious disease to include Hepatitis B and C, human immunodeficiency virus infection (HIV1/2), Human t-lymphotropic virus (HTLV I/II) and syphilis
Patients who have received any cytotoxic therapy (including investigational products) within three weeks prior to tissue procurement
For selected solid tumours and leukapheresis procedure additional exclusion criteria apply
Clinical status precludes surgical removal of, or collection of multiple biopsies from, accessible tumour tissue
For selected solid tumours additional exclusion criteria may apply
Patients who are currently participating in a clinical trial involving an unlicensed medical product
Patients receiving immunosuppressive treatments or who require regular treatment with steroids at a dose higher than prednisolone 10 mg/day (or equivalent)
Any medical reason why, in the opinion of the investigator, the patient should not participate in this study
Clear my responses

How to participate?

Step 1 Connect with a study center
What happens next?
  • You can expect the study team to contact you via email or phone in the next few days.
  • Sign up as volunteer  to help accelerate the development of new treatments and to get notified about similar trials.

You are contacting

Investigator Avatar

Primary Contact


Additional screening procedures may be conducted by the study team before you can be confirmed eligible to participate.

Learn more

If you are confirmed eligible after full screening, you will be required to understand and sign the informed consent if you decide to enroll in the study. Once enrolled you may be asked to make scheduled visits over a period of time.

Learn more

Complete your scheduled study participation activities and then you are done. You may receive summary of study results if provided by the sponsor.

Learn more

Similar trials to consider


Browse trials for

Not finding what you're looking for?

Every year hundreds of thousands of volunteers step forward to participate in research. Sign up as a volunteer and receive email notifications when clinical trials are posted in the medical category of interest to you.

Sign up as volunteer

user name

Added by • 



Reply by • Private

Lorem ipsum dolor sit amet consectetur, adipisicing elit. Ipsa vel nobis alias. Quae eveniet velit voluptate quo doloribus maxime et dicta in sequi, corporis quod. Ea, dolor eius? Dolore, vel!

  The passcode will expire in None.

No annotations made yet

Add a private note
  • abc Select a piece of text from the left.
  • Add notes visible only to you.
  • Send it to people through a passcode protected link.
Add a private note